Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
11 |
Material Type: Artigo
|
![]() |
How Does the Additional Benefit Extend of Orphan Drugs Impact Price Negotiations in the German Outpatient Sector?Schwarz, R ; Freiberg, MValue in health, 2016-11, Vol.19 (7), p.A600-A600 [Periódico revisado por pares]Texto completo disponível |
12 |
Material Type: Artigo
|
![]() |
Seasonal shifts in population structure of Vibrio vulnificus in an estuarine environment as revealed by partial 16S ribosomal DNA sequencingLin, Meilan ; Schwarz, John RFEMS microbiology ecology, 2003-07, Vol.45 (1), p.23-27 [Periódico revisado por pares]Oxford, UK: Elsevier B.VTexto completo disponível |
13 |
Material Type: Artigo
|
![]() |
Separation of M‐like current and ERG current in NG108‐15 cellsMeves, Hans ; Schwarz, Jürgen R ; Wulfsen, IrisBritish journal of pharmacology, 1999-07, Vol.127 (5), p.1213-1223 [Periódico revisado por pares]Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
14 |
Material Type: Artigo
|
![]() |
PMD39 HOSPITAL REIMBURSEMENT PATHWAYS FOR NEW EXAMINATION AND TREATMENT METHODS IN GERMANYWorf, K. ; Schuh, I. ; Scheler, E. ; Schwarz, R. ; Bonduelle, D.Value in health, 2019-11, Vol.22, p.S676-S676 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
15 |
Material Type: Artigo
|
![]() |
PHP16 - Biosimilars: Market Access and Market Penetration – A Comparison of France and GermanyFreiberg, M ; Schwarz, R ; Khoury, CValue in health, 2016-11, Vol.19 (7), p.A442-A442 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
16 |
Material Type: Artigo
|
![]() |
Biosimilars: Market Access and Market Penetration – A Comparison of France and GermanyFreiberg, M ; Schwarz, R ; Khoury, CValue in health, 2016-11, Vol.19 (7), p.A442-A442 [Periódico revisado por pares]Texto completo disponível |
17 |
Material Type: Artigo
|
![]() |
Out-patient behaviour therapy in alcoholism: treatment outcome after 2 yearsBurtscheidt, W. ; Wölwer, W. ; Schwarz, R. ; Strauss, W. ; Gaebel, W.Acta psychiatrica Scandinavica, 2002-09, Vol.106 (3), p.227-232 [Periódico revisado por pares]Oxford UK: Munksgaard International PublishersTexto completo disponível |
18 |
Material Type: Artigo
|
![]() |
PHP206 - How Does The Additional Benefit Extent of Orphan Drugs Impact Price Negotiations In The German Outpatient Sector?Freiberg, M ; Schwarz, R ; Fath, FValue in health, 2015-11, Vol.18 (7), p.A550-A550 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
19 |
Material Type: Artigo
|
![]() |
How Does The Additional Benefit Extent of Orphan Drugs Impact Price Negotiations In The German Outpatient Sector?Freiberg, M ; Schwarz, R ; Fath, FValue in health, 2015-11, Vol.18 (7), p.A550-A550 [Periódico revisado por pares]United StatesTexto completo disponível |
20 |
Material Type: Artigo
|
![]() |
Update on Impact of The Additional Benefit Extent of Orphan Drugs on Price Negotiations In The German Outpatient SectorFreiberg, M ; Schwarz, R ; Schalk, E ; Kraft, TValue in health, 2017-10, Vol.20 (9), p.A568 [Periódico revisado por pares]Lawrenceville: Elsevier Science LtdTexto completo disponível |